Fred Hassan - Jan 3, 2025 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Director
Signature
/s/ Ron Honig, Attorney-in-Fact
Stock symbol
EYPT
Transactions as of
Jan 3, 2025
Transactions value $
$0
Form type
4
Date filed
1/7/2025, 04:05 PM
Previous filing
Oct 11, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.